蘇寧易購(002024.SZ):已完成回購方案 累計回購約10.11億元的股份
格隆匯 8 月 17日丨蘇寧易購(002024.SZ)公佈,公司於2019年11月4日首次以集中競價方式實施回購股份,並於2019年11月5日披露《關於首次回購公司股份暨回購公司股份的進展公告》,公司實際回購股份區間為2019年11月4日至2020年8月6日,累計通過回購專用證券賬户以集中競價交易方式回購公司股份101,482,037股,佔公司總股本的1.09%,最高成交價為11.15元/股,最低成交價為8.26元/股,支付的總金額約10.11億元(不含交易費用)。為此公司此次回購股份實施完畢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.